http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09509422-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 1995-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09509422-A |
| titleOfInvention | 2- (Aminoalkoxy) phenylalkylamines with anti-inflammatory activity |
| abstract | (57) [Summary] Formula I: Wherein, R 1, R 2, R 3 and R 4 are independently hydrogen, hydroxy, halo, halogenated alkyl, halogenated alkoxy, alkyl, alkoxy, cyano, wherein: CONR A carbamoyl group R B, alkoxy, Represents a carbonyl group or R 1 and R 2 together with the phenyl ring represent a naphthalene ring (optionally substituted); L 1 optionally comprises one or more C 1 -C 4 alkyl groups substituted represents an C 2 -C 6 alkylene; R 5 represents hydrogen or alkyl, or R 6 represents hydrogen or alkyl, phenylalkyl (optionally substituted), or R 5 and R 6 represents a saturated 3 to 7 membered heterocycle together with the nitrogen atom to which they are attached; L 2 is optionally substituted by one or more C 1 to C 4 alkyl groups C 1 ~ Represents a C 6 alkylene chain; and R 7 and R 8 independently represent hydrogen or alkyl, or R 7 and R 8 together with the nitrogen atom to which they are bonded are saturated 3 to 7 membered heterocycles. A compound (provided that there is a proviso) for the treatment of an anti-inflammatory agent and / or an anti-allergic agent and / or a rheumatic disease and / or a nerve injury. It is an immunomodulator that is effective against. Compositions containing this compound and methods of making the same have also been found. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021119151-A |
| priorityDate | 1994-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 289.